Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02511236 · ClinicalTrials.gov registry record · Phase 4
Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention
A Phase 4 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 356
- Enrollment target
NCT02511236 is a Phase 4 study that has completed, run by University of Miami. The registered enrollment target is 356 participants.
The verdict
NCT02511236, a Phase 4 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 356 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effects of a group smoking cessation program. The study will also examine individual differences in response to the intervention program.
Interventions
- DRUG Transdermal Nicotine Patch
- BEHAVIORAL General Health Education
- BEHAVIORAL Group Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 356 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-10-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02511236
The ClinicalTrials.gov registry entry for NCT02511236 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 356 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Transdermal Nicotine Patch is the first listed.
NCT02511236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02511236 about?
NCT02511236 is a clinical study titled "Addressing Racial/Ethnic Tobacco Health Disparities Via Group Intervention". The purpose of this study is to test the effects of a group smoking cessation program. The study will also examine individual differences in response to the intervention program.
What is the current status of trial NCT02511236?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 356 participants. The study started on 2015-08. Estimated completion is 2019-10-23.
What interventions are being tested in trial NCT02511236?
The interventions under investigation include: Transdermal Nicotine Patch (DRUG), General Health Education (BEHAVIORAL), Group Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02511236?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.